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Use of the Sideguard (Cappella) stent in 
bifurcation lesions: a real-world experience 
 
Abstract 
AIMS:  
The Sideguard® stent (Cappella Medical Devices Ltd, Galway, Ireland), is a novel nitinol 
self-expanding dedicated bifurcation stent that flares proximally at the ostium of the side 
branch (SB) into a trumpet shape thereby achieving full ostial coverage. The aim of this study 
is to report the utility and limitations of this stent in patients undergoing treatment to 
bifurcation coronary lesions in a real-world setting. 
METHODS AND RESULTS:  
We prospectively identified 20 successive patients admitted over a 6-month period in whom 
there was significant SB disease and who were suitable for a bifurcation procedure. The 
Sideguard® stent was successfully used in all 20 cases including several that would have been 
technically difficult using conventional bifurcation techniques. We highlight use of this 
system using five illustrative cases that illustrate its utility and limitations in the treatment of 
bifurcation lesions. 
CONCLUSIONS:  
The Sideguard® stent can be used to treat complex bifurcation lesions in a straight forward 
manner and is not subject to the limitations associated with conventional bifurcation PCI 
techniques including jailing of the SB ostium and inability to fully cover/scaffold the ostium 
of the SB. 
 
